CareLit Fachartikel
Experience of up to ten years treatment with albumin-diluted botulinum toxin type A
B Mohammadi, K Kollewe, M Wegener, K Krampfl, R Dengler · Klinische Neurophysiologie · 2008 · Heft 01
Dokument
1043508
CareLit-ID
Jahr
2008
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig
Bibliografische Angaben
Zusammenfassung
Introduction: Only few data regarding the long-term follow-up of patients treated with albumin-diluted botulinum toxin (BTX) type A (Dysport®) have been published to date. In this study we present the data of 177 patients who received albumin-diluted BTX type A over a period of up to ten years with the diagnosis of dystonia, spasticity, writers cramp, blepharospasm, facial hemispasm and hyperhidrosis. Methods: We performed a retrospective study of 177 patients who were treated in our BTX-outpatient clinic with albumin-diluted BTX type A (Dysport®) between 1996 and 2006. The toxin was diluted in 20ml of 0.1% albu…
Schlagworte
Blepharospasm
Diagnosis
After
Antibodies
Population
Database
Chicago
Klinische Neurophysiologie
